NCT01999140 Implantable Cardioverter Defibrillator (ICD Registry)
| NCT ID | NCT01999140 |
| Status | Recruiting |
| Phase | — |
| Sponsor | American College of Cardiology |
| Condition | Heart Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,750 participants |
| Start Date | 2005-06 |
| Primary Completion | 2030-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,750 participants in total. It began in 2005-06 with a primary completion date of 2030-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The ICD Registry™ is a nationwide quality program that helps participating hospitals measure and improve care for patients receiving implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy devices with defibrillator (CRT-Ds). The ICD Registry captures the characteristics, treatments, and outcomes of patients receiving (ICDs). Patient-level data is submitted by participating hospitals on a quarterly basis to the American College of Cardiology Foundation's (ACCF) National Cardiovascular Data Registry (NCDR) which then produces an Outcomes Report of the hospital's data, with comparison to both a volume peer group (number of ICD patients submitted annually) and the entire ICD registry data set.
Eligibility Criteria
All U.S and International patients. Inclusion Criteria: * All patients who receive an ICD/CRT-D (initial or generator change) for primary or secondary prevention purposes. * All patients with an ICD/CRT-D undergoing a Lead Only procedure. * U.S. populations must submit all patients who receive an ICD/CRT-D (initial or generator change) for primary prevention purposes who are insured by Medicare. Exclusion Criteria: None
Contact & Investigator
Frequently Asked Questions
Who can join the NCT01999140 clinical trial?
This trial is open to participants of all sexes, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01999140 currently recruiting?
Yes, NCT01999140 is actively recruiting participants. Contact the research team at ncdr@acc.org for enrollment information.
Where is the NCT01999140 trial being conducted?
This trial is being conducted at Washington D.C., United States.
Who is sponsoring the NCT01999140 clinical trial?
NCT01999140 is sponsored by American College of Cardiology. The trial plans to enroll 1,750 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.